increased circulating glucose level_Prkdc<scid>/Prkdc<scid>

http://metadb.riken.jp/0005559NODCB17PrkdcscidJPrkdcscidPrkdcscidPrkdcscid

increased circulating glucose level_Prkdc<scid>/Prkdc<scid>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• protein kinase, DNA activated, catalytic polypeptide
  http://metadb.riken.jp/db/mgi_rdf/MGI:104779

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Prkdc<scid>/Prkdc<scid>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Prkdc<scid>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• NOD.CB17-Prkdc<scid>/J

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased circulating glucose level
  http://purl.obolibrary.org/obo/MP_0005559

文献

http://purl.org/net/cito/citesAsAuthority

• Scott J. Banuelos, et.al., Rejection of human islets and human HLA-A2.1 transgenic mouse islets by alloreactive human lymphocytes in immunodeficient NOD-scid and NOD-Rag1(null)Prf1(null) mice., Clinical immunology (Orlando, Fla.), 2004, 112
  http://rdf.ncbi.nlm.nih.gov/pubmed/15308121